Back to Journals » Neuropsychiatric Disease and Treatment » Volume 6 » Issue 1

Review

Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients

          
Total article views   Abstract views HTML views PDF downloads Totals
14,932 Dovepress* 11,410 472+ 2,135 11,882
PubMed Central* 20 3,030 732 3,050
Totals 11,430 3,502 2,867 14,932
*Since 10 November 2010
+Since July 2016

View citations on PubMed Central and Google Scholar